CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Entecavir

恩替卡韦 杂质对照品Entecavir Impurities

EP59 个杂质条目59 impurity entries

本页汇总 恩替卡韦 的 59 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 59 impurity reference standards of Entecavir with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 恩替卡韦(Entecavir)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous determination of related substances in entecavir film-coated tablet by high performance liquid chromatography
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2021 · Zhang Y, Yuan H  ·  PMID 34704414  ·  DOI
  2. 杂质研究Impurity studiesSelective Determination of Entecavir in the Presence of its Oxidative Degradate by Spectrophotometric and Chromatographic Methods
    Journal of AOAC International · 2021 · El-Sayed HM et al.  ·  PMID 33528014  ·  DOI
  3. 杂质研究Impurity studiesValidation of a stability-indicating RP-HPLC method for the determination of entecavir in tablet dosage form
    Journal of AOAC International · 2010 · Dalmora SL et al.  ·  PMID 20480899

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of (R)- and (S)-4-Hydroxy-2-cyclopenten-1-ones: Total Synthesis of Entecavir, Abacavir, and Carbovir
    The Journal of organic chemistry · 2025 · Li N et al.  ·  PMID 40910633  ·  DOI
  • 合成方法SynthesisAsymmetric Total Synthesis of Anti-HBV Drug Entecavir: Catalytic Strategies for the Stereospecific Construction of Densely Substituted Cyclopentene Cores
    Organic letters · 2024 · Zhang GT et al.  ·  PMID 38809781  ·  DOI

恩替卡韦 —— 原料药与杂质对照品Entecavir — drug substance & impurities

共 60 个条目(含原料药本体)60 items incl. the drug substance
Entecavir structure
EP原料药 APIAPI
恩替卡韦Entecavir
Entecavir
CAS No.142217-69-4
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 6 (Entecavir Monohydrate EP Impurity A) structure
EPA
恩替卡韦杂质6 (恩替卡韦一水合物EP杂质A)Entecavir Impurity 6 (Entecavir Monohydrate EP Impurity A)
Entecavir Impurity 6 (Entecavir Monohydrate EP Impurity A)
CAS No.1367369-78-5
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 7 (Entecavir Monohydrate EP Impurity B) structure
EPB
恩替卡韦杂质7 (恩替卡韦一水合物EP杂质B)Entecavir Impurity 7 (Entecavir Monohydrate EP Impurity B)
Entecavir Impurity 7 (Entecavir Monohydrate EP Impurity B)
CAS No.1367369-77-4
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 5 (Entecavir Monohydrate EP Impurity D) structure
EPD
恩替卡韦杂质5 (恩替卡韦一水合物EP杂质D)Entecavir Impurity 5 (Entecavir Monohydrate EP Impurity D)
Entecavir Impurity 5 (Entecavir Monohydrate EP Impurity D)
CAS No.1367369-80-9
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 9 (Entecavir Monohydrate EP Impurity E) structure
EPE
恩替卡韦杂质9 (恩替卡韦一水合物EP杂质E)Entecavir Impurity 9 (Entecavir Monohydrate EP Impurity E)
Entecavir Impurity 9 (Entecavir Monohydrate EP Impurity E)
CAS No.2349444-69-3
Chemical FormulaC13H17N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 19 (Entecavir Monohydrate EP Impurity F) structure
EPF
恩替卡韦杂质19 (恩替卡韦一水合物EP杂质F)Entecavir Impurity 19 (Entecavir Monohydrate EP Impurity F)
Entecavir Impurity 19 (Entecavir Monohydrate EP Impurity F)
CAS No.649761-24-0
Chemical FormulaC27H31N5O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 1 structure
1
恩替卡韦杂质1Entecavir Impurity 1
Entecavir Impurity 1
CAS No.1367369-76-3
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 2 structure
2
恩替卡韦杂质2Entecavir Impurity 2
Entecavir Impurity 2
CAS No.1367369-79-6
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 3 structure
3
恩替卡韦杂质3Entecavir Impurity 3
Entecavir Impurity 3
CAS No.188399-46-4
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 4 structure
4
恩替卡韦杂质4Entecavir Impurity 4
Entecavir Impurity 4
CAS No.1367369-81-0
Chemical FormulaC12H15N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 13 structure
13
恩替卡韦杂质13Entecavir Impurity 13
Entecavir Impurity 13
CAS No.142217-78-5
Chemical FormulaC52H49N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 14 structure
14
恩替卡韦杂质14Entecavir Impurity 14
Entecavir Impurity 14
CAS No.142217-79-6
Chemical FormulaC52H47N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 15 structure
15
恩替卡韦杂质15Entecavir Impurity 15
Entecavir Impurity 15
CAS No.142217-80-9
Chemical FormulaC53H49N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 16 structure
16
恩替卡韦杂质16Entecavir Impurity 16
Entecavir Impurity 16
CAS No.142217-81-0
Chemical FormulaC26H27N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 18 structure
18
恩替卡韦杂质18Entecavir Impurity 18
Entecavir Impurity 18
CAS No.1030919-51-7
Chemical FormulaC19H21N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 20 structure
20
恩替卡韦杂质20Entecavir Impurity 20
Entecavir Impurity 20
CAS No.1984788-96-6
Chemical FormulaC12H15N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 21 structure
21
恩替卡韦杂质21Entecavir Impurity 21
Entecavir Impurity 21
CAS No.84868-56-4
Chemical FormulaC21H20O2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 22 structure
22
恩替卡韦杂质22Entecavir Impurity 22
Entecavir Impurity 22
CAS No.870614-82-7
Chemical FormulaC14H21N5O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 23 structure
23
恩替卡韦杂质23Entecavir Impurity 23
Entecavir Impurity 23
CAS No.110567-21-0
Chemical FormulaC13H16O2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 29 structure
29
恩替卡韦杂质29Entecavir Impurity 29
Entecavir Impurity 29
CAS No.3032770-33-2
Chemical FormulaC11H15N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 36 structure
36
恩替卡韦杂质36Entecavir Impurity 36
Entecavir Impurity 36
CAS No.142217-77-4
Chemical FormulaC32H33N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 37 structure
37
恩替卡韦杂质37Entecavir Impurity 37
Entecavir Impurity 37
CAS No.1354695-82-1
Chemical FormulaC26H27N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 42 structure
42
恩替卡韦杂质42Entecavir Impurity 42
Entecavir Impurity 42
CAS No.1415118-52-3
Chemical FormulaC15H19N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 43 structure
43
恩替卡韦杂质43Entecavir Impurity 43
Entecavir Impurity 43
CAS No.1415118-53-4
Chemical FormulaC15H19N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 45 structure
45
恩替卡韦杂质45Entecavir Impurity 45
Entecavir Impurity 45
CAS No.1354715-30-2
Chemical FormulaC17H22ClN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 47 structure
47
恩替卡韦杂质47Entecavir Impurity 47
Entecavir Impurity 47
CAS No.117641-39-1
Chemical FormulaC13H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 48 structure
48
恩替卡韦杂质48Entecavir Impurity 48
Entecavir Impurity 48
CAS No.110567-22-1
Chemical FormulaC20H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 49 structure
49
恩替卡韦杂质49Entecavir Impurity 49
Entecavir Impurity 49
CAS No.1354695-84-3
Chemical FormulaC26H27N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 50 structure
50
恩替卡韦杂质50Entecavir Impurity 50
Entecavir Impurity 50
CAS No.1354695-86-5
Chemical FormulaC26H27N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 51 structure
51
恩替卡韦杂质51Entecavir Impurity 51
Entecavir Impurity 51
CAS No.1354695-85-4
Chemical FormulaC26H27N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 52 structure
52
恩替卡韦杂质52Entecavir Impurity 52
Entecavir Impurity 52
CAS No.39939-07-6
Chemical FormulaC13H14O
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 54 structure
54
恩替卡韦杂质54Entecavir Impurity 54
Entecavir Impurity 54
CAS No.3587-60-8
Chemical FormulaC8H9ClO
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 66 structure
66
恩替卡韦杂质66Entecavir Impurity 66
Entecavir Impurity 66
CAS No.204845-95-4
Chemical FormulaC33H33N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 71 structure
71
恩替卡韦杂质71Entecavir Impurity 71
Entecavir Impurity 71
CAS No.701278-19-5
Chemical FormulaC21H24O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 72 structure
72
恩替卡韦杂质72Entecavir Impurity 72
Entecavir Impurity 72
CAS No.701278-18-4
Chemical FormulaC21H24O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 73 structure
73
恩替卡韦杂质73Entecavir Impurity 73
Entecavir Impurity 73
CAS No.41787-51-3
Chemical FormulaC15H18O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 79 structure
79
恩替卡韦杂质79Entecavir Impurity 79
Entecavir Impurity 79
CAS No.1354695-76-9
Chemical FormulaC53H49N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 80 structure
80
恩替卡韦杂质80Entecavir Impurity 80
Entecavir Impurity 80
CAS No.1354695-80-9
Chemical FormulaC53H49N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 82 structure
82
恩替卡韦杂质82Entecavir Impurity 82
Entecavir Impurity 82
CAS No.1354695-78-5
Chemical FormulaC53H49N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 84 structure
84
恩替卡韦杂质84Entecavir Impurity 84
Entecavir Impurity 84
CAS No.1354695-81-0
Chemical FormulaC53H49N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 90 structure
90
恩替卡韦杂质90Entecavir Impurity 90
Entecavir Impurity 90
CAS No.1354695-76-3
Chemical FormulaC52H49N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 91 structure
91
恩替卡韦杂质91Entecavir Impurity 91
Entecavir Impurity 91
CAS No.1104620-14-5
Chemical FormulaC52H49N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 92 structure
92
恩替卡韦杂质92Entecavir Impurity 92
Entecavir Impurity 92
CAS No.1354695-72-9
Chemical FormulaC52H49N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 97 structure
97
恩替卡韦杂质97Entecavir Impurity 97
Entecavir Impurity 97
CAS No.1354695-70-7
Chemical FormulaC52H49N5O5
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 121 structure
121
恩替卡韦杂质121Entecavir Impurity 121
Entecavir Impurity 121
CAS No.2170087-66-6
Chemical FormulaC20H17ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 125 structure
125
恩替卡韦杂质125Entecavir Impurity 125
Entecavir Impurity 125
CAS No.873298-16-9
Chemical FormulaC20H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 132 structure
132
恩替卡韦杂质132Entecavir Impurity 132
Entecavir Impurity 132
CAS No.701278-59-3
Chemical FormulaC13H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 133 structure
133
恩替卡韦杂质133Entecavir Impurity 133
Entecavir Impurity 133
CAS No.325480-49-7
Chemical FormulaC13H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 134 structure
134
恩替卡韦杂质134Entecavir Impurity 134
Entecavir Impurity 134
CAS No.1353742-19-4
Chemical FormulaC13H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 139 structure
139
恩替卡韦杂质139Entecavir Impurity 139
Entecavir Impurity 139
CAS No.188399-48-6
Chemical FormulaC13H16O2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 140 structure
140
恩替卡韦杂质140Entecavir Impurity 140
Entecavir Impurity 140
CAS No.325480-40-8
Chemical FormulaC13H16O2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 146 structure
146
恩替卡韦杂质146Entecavir Impurity 146
Entecavir Impurity 146
CAS No.1345339-53-8
Chemical FormulaC51H47N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 164 structure
164
恩替卡韦杂质164Entecavir Impurity 164
Entecavir Impurity 164
CAS No.701278-07-1
Chemical FormulaC20H25N5O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 170 structure
170
恩替卡韦杂质170Entecavir Impurity 170
Entecavir Impurity 170
CAS No.701278-13-9
Chemical FormulaC19H21N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 174 structure
174
恩替卡韦杂质174Entecavir Impurity 174
Entecavir Impurity 174
CAS No.2203740-23-0
Chemical FormulaC13H17N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 175 structure
175
恩替卡韦杂质175Entecavir Impurity 175
Entecavir Impurity 175
CAS No.2613003-85-1
Chemical FormulaC22H21ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 178 structure
178
恩替卡韦杂质178Entecavir Impurity 178
Entecavir Impurity 178
CAS No.40615-36-9
Chemical FormulaC21H19ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 179 structure
179
恩替卡韦杂质179Entecavir Impurity 179
Entecavir Impurity 179
CAS No.2204369-23-1
Chemical FormulaC12H15N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 180 structure
180
恩替卡韦杂质180Entecavir Impurity 180
Entecavir Impurity 180
CAS No.191480-69-0
Chemical FormulaC20H22O2
Purity>95%询价On request
10mg25mg50mg100mg
Entecavir Impurity 185 structure
185
恩替卡韦杂质185Entecavir Impurity 185
Entecavir Impurity 185
CAS No.1829-26-1
Chemical FormulaC9H7IO4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

恩替卡韦 —— 研究文献与合成路线Entecavir — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 恩替卡韦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Entecavir. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. LC-MS/MS method for the characterization of the forced degradation products of Entecavir
    Ramesh T, Rao PN, Rao RN · Journal of separation science · 2014 · 被引 7cited 7
  2. Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy
    Kang Y, Shao Z, Wang Q, et al. · Journal of pharmaceutical and biomedical analysis · 2018 · 被引 11cited 11
  3. Selective Determination of Entecavir in the Presence of its Oxidative Degradate by Spectrophotometric and Chromatographic Methods
    El-Sayed HM, Abdel Fattah LE, Abdellatef HE, et al. · Journal of AOAC International · 2021 · 被引 1cited 1
  4. Chiral detection of entecavir stereoisomeric impurities through coordination with R-besivance and ZnII using mass spectrometry
    Wang Y, Wang L, Chen X, et al. · Journal of mass spectrometry : JMS · 2018 · 被引 2cited 2
  5. Simultaneous determination of related substances in entecavir film-coated tablet by high performance liquid chromatography
    Zhang Y, Yuan H · Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2021 · 被引 1cited 1
  6. Validation of a stability-indicating RP-HPLC method for the determination of entecavir in tablet dosage form
    Dalmora SL, Sangoi Mda S, Nogueira DR, et al. · Journal of AOAC International · 2010 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. Process for Preparing Entecavir and its Intermediates
    HU TSUNG-CHENG, HUANG HUNG-TSUNG · 公开号 US2011201809US2011201809 · 2011
  2. PROCESS FOR PREPARING ENTECAVIR AND ITS INTERMEDIATES
    HU TSUNG-CHENG, HUANG HUNG-TSUNG · 公开号 WO2011102806WO2011102806 · 2011
  3. NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME
    LEE JAEHEON, PARK GHA-SEUNG, KIM JIN HEE, LEE JI EUN, et al. · 公开号 WO2010074534WO2010074534 · 2010
  4. NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME
    LEE JAEHEON, PARK GHA-SEUNG, KIM JIN HEE, LEE JI EUN, et al. · 公开号 EP2382217EP2382217 · 2011
  5. NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME
    LEE JAEHEON, PARK GHA-SEUNG, KIM JIN HEE, LEE JI EUN, et al. · 公开号 US2011251387US2011251387 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

恩替卡韦 杂质谱研究要点Entecavir — impurity profiling notes

下面这些是拿到 恩替卡韦 的 60 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 60 impurity entries for Entecavir, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances